Structural, genomic information and computational analysis of emerging coronavirus (SARS-CoV-2)

[1] Adhikari SP(2020)Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review Infect Dis Poverty 9 1-12

[2] Meng S(2018)Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease Mbio 9 e00221-e318

[3] Wu Y(2020)Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies Viruses 12 254-173

[4] Mao YP(2020)Comprehensive evolution and molecular characteristics of a large number of SARS-CoV-2 genomes reveal its epidemic trends Int J Infect Dis 100 164-1033

[5] Ye RX(2012)The SARS-like coronaviruses: the role of bats and evolutionary relationships with SARS coronavirus Microbiol Q J Microbiol Sci 35 1-522

[6] Wang QZ(2020)Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a Drug-Target Interaction Deep Learning Model Biorxiv 4 1011-423

[7] Zhou H(2012)Mechanisms of coronavirus cell entry mediated by the viral spike protein Viruses 28 465-60

[8] Agostini ML(2015)Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease Clin Microbiol Rev 92 418-1976

[9] Andres EL(2020)Emerging coronaviruses: genome structure, replication, and pathogenesis J Med Virol 14 523-3212

[10] Sims AC(2016)SARS and MERS: recent insights into emerging coronaviruses Nat Rev Microbiol 14 58-240

[1] Adhikari SP(2020)Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review Infect Dis Poverty 9 1-12

[2] Meng S(2018)Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease Mbio 9 e00221-e318

[3] Wu Y(2020)Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies Viruses 12 254-173

[4] Mao YP(2020)Comprehensive evolution and molecular characteristics of a large number of SARS-CoV-2 genomes reveal its epidemic trends Int J Infect Dis 100 164-1033

[5] Ye RX(2012)The SARS-like coronaviruses: the role of bats and evolutionary relationships with SARS coronavirus Microbiol Q J Microbiol Sci 35 1-522

[6] Wang QZ(2020)Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a Drug-Target Interaction Deep Learning Model Biorxiv 4 1011-423

[7] Zhou H(2012)Mechanisms of coronavirus cell entry mediated by the viral spike protein Viruses 28 465-60

[8] Agostini ML(2015)Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease Clin Microbiol Rev 92 418-1976

[9] Andres EL(2020)Emerging coronaviruses: genome structure, replication, and pathogenesis J Med Virol 14 523-3212

[10] Sims AC(2016)SARS and MERS: recent insights into emerging coronaviruses Nat Rev Microbiol 14 58-240